Statera Biopharma, Inc. 4 SEC Filings

Filed On	Filing
28 Oct 2021	Form 4: Saluck Randy S., Director Received 60,000 shares as a grant or award
19 Oct 2021	Form 4: Barbarick Steve K, Director Received 60,000 shares as a grant or award
19 Oct 2021	Form 4: Verny Lea, Director Received 60,000 shares as a grant or award
30 Sep 2021	Form 4: Markvicka Taunia, Director Received 100,000 shares as a grant or award
04 Aug 2021	Form 4: Handley Michael K, Director Received 296,609 shares as a grant or award
29 Jul 2021	Form 4: Buckheit Robert, Chief Technology Officer Received 24,378 shares as a grant or award
29 Jul 2021	Form 4: Selsky Clifford, Chief Medical Officer Received 101,579 shares as a grant or award
29 Jul 2021	Form 4: McAvoy Cozette M., Chief Legal Officer Received 60,947 shares as a grant or award
29 Jul 2021	Form 4: Aronstam Peter, Chief Financial Officer Received 141,370 shares as a grant or award
23 Jul 2021	Form 4: Miller Langdon L, Chief Medical Officer Received 10,000 shares by exercise or conversion ($30K)
06 May 2015	Form 4: Miller Langdon L, President & CMO Granted 10,000 Stock Option (right to buy)
24 Apr 2015	Form 4: Kogan Yakov, Director Granted 12,500 Stock Option (right to buy)
24 Apr 2015	Form 4: Lyons C Neil, Chief Financial Officer Granted 6,250 Stock Option (right to buy)
24 Apr 2015	Form 4: Gudkov Andrei V, Director Granted 6,250 Stock Option (right to buy)
24 Apr 2015	Form 4: Saluck Randy S., Director Granted 16,000 Stock Option (right to buy)
24 Apr 2015	Form 4: Principi Anthony, Director Granted 16,000 Stock Option (right to buy)
24 Apr 2015	Form 4: McGowan Richard, Director Granted 16,000 Stock Option (right to buy)
24 Apr 2015	Form 4: Kasimova Elena, Director Granted 16,000 Stock Option (right to buy)
24 Apr 2015	Form 4: Antal James, Director Granted 16,000 Stock Option (right to buy)
27 Feb 2015	Form 4: Saluck Randy S., Director Bought 1,891 shares ($6.47K)

Comments